Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/54450
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMielgo Rubio, Xabier-
dc.contributor.authorMontemuiño Muñiz, Sara-
dc.contributor.authorJiménez, Unai-
dc.contributor.authorLuna, Javier-
dc.contributor.authorCardeña, Ana-
dc.contributor.authorMezquita, Laura-
dc.contributor.authorMartín, Margarita-
dc.contributor.authorCouñago, Felipe-
dc.date.accessioned2021-10-08T10:52:29Z-
dc.date.available2021-10-08T10:52:29Z-
dc.date.issued2021-09-27-
dc.identifier.citationMielgo-Rubio X, Montemuiño Muñiz S, Jiménez U, Luna J, Cardeña A, Mezquita L, et al. Management of resectable stage III-N2 non-small-cell lung cancer (NSCLC) in the age of immunotherapy. Cancers. 2021;13(19):4811.es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12530/54450-
dc.language.isoenes_ES
dc.publisherMDPI AGes_ES
dc.relation.isversionofPreprintes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject.meshCarcinoma, Non-Small-Cell Lung-
dc.subject.meshImmunotherapy-
dc.titleManagement of resectable stage III-N2 non-small-cell lung cancer (NSCLC) in the age of immunotherapyes_ES
dc.typeArtículoes_ES
dc.format.volume13es_ES
dc.format.page4811es_ES
dc.description.peerreviewedes_ES
dc.identifier.journalCancerses_ES
dc.contributor.authoraffiliationServicio de Oncología Radioterápica. Hospital Universitario de Fuenlabradaes_ES
dc.format.number19es_ES
dc.subject.decsCarcinoma de Pulmón de Células no Pequeñas-
dc.subject.decsInmunoterapia-
Appears in Collections:Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:
File Description SizeFormat 
Cancers.pdf294,98 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons